» Articles » PMID: 25758281

Transjugular Intrahepatic Portosystemic Shunt Versus Surgical Shunting in the Management of Portal Hypertension

Overview
Specialty General Medicine
Date 2015 Mar 12
PMID 25758281
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this article was to clarify the optimal management concerning transjugular intrahepatic portosystemic shunts (TIPSs) and surgical shunting in treating portal hypertension.

Methods: All databases, including CBM, CNKI, WFPD, Medline, EMBASE, PubMed and Cochrane up to February 2014, were searched for randomized controlled trials (RCTs) comparing TIPS with surgical shunting. Four RCTs, which were extracted by two independent investigators and were evaluated in postoperative complications, mortality, 2- and 5-year survival, hospital stay, operating time and hospitalization charges.

Results: The morbidity in variceal rehemorrhage was significantly higher in TIPS than in surgical shunts (odds ratio [OR] = 7.45, 95% confidence interval[CI]: (3.93-14.15), P < 0.00001), the same outcomes were seen in shunt stenosis (OR = 20.01, 95% CI: (6.67-59.99), P < 0.000001) and in hepatic encephalopathy (OR = 2.50, 95% CI: (1.63-3.84), P < 0.0001). Significantly better 2-year survival (OR = 0.66; 95% CI: (0.44-0.98), P = 0.04) and 5-year survival (OR = 0.44; 95% CI: (0.30-0.66), P < 0.00001) were seen in patients undergoing surgical shunting compared with TIPS.

Conclusions: Compared with TIPS, postoperative complications and survival after surgical shunting were superior for patients with portal hypertension. Application of surgical shunting was recommended for patients rather than TIPS.

Citing Articles

Surgical portosystemic shunts versus transjugular intrahepatic portosystemic shunt for variceal haemorrhage in people with cirrhosis.

Brand M, Prodehl L, Ede C Cochrane Database Syst Rev. 2018; 10:CD001023.

PMID: 30378107 PMC: 6516991. DOI: 10.1002/14651858.CD001023.pub3.

References
1.
Bureau C, Carlos Garcia Pagan J, Layrargues G, Metivier S, Bellot P, Perreault P . Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int. 2007; 27(6):742-7. DOI: 10.1111/j.1478-3231.2007.01522.x. View

2.
Boyer T, Henderson J, Heerey A, Arrigain S, Konig V, Connor J . Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol. 2007; 48(3):407-14. PMC: 2743029. DOI: 10.1016/j.jhep.2007.08.014. View

3.
Saad W, Saad N, Koizumi J . Stomal varices: management with decompression tips and transvenous obliteration or sclerosis. Tech Vasc Interv Radiol. 2013; 16(2):176-84. DOI: 10.1053/j.tvir.2013.02.005. View

4.
Costa G, Cruz Jr R, Abu-Elmagd K . Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am. 2010; 90(4):891-905. DOI: 10.1016/j.suc.2010.04.015. View

5.
Smith M, Rase B, Woods A, Trotter J, Gipson M, Kondo K . Risk of hernia incarceration following transjugular intrahepatic portosystemic shunt placement. J Vasc Interv Radiol. 2013; 25(1):58-62. DOI: 10.1016/j.jvir.2013.09.003. View